Our active studies are designed to explore new therapies that may improve outcomes, expand treatment choices, and help shape the future of patient care.
Active disease confirmed by symptoms and endoscopy
Adults diagnosed with inflammatory bowel disease (UC)
Requires confirmed diagnosis of advanced or metastatic cancer
Adults receiving cancer therapy who have developed a treatment-related skin rash
Requires a recent diagnosis of cancer ( ≤ 90 days)
Adults or children with flu-like symptoms, symptom onset of ≤ 3 days
Additional eligibility criteria apply. Final eligibility is determined by the study team following screening.
Copyright © 2025 Regis Clinical Research - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.